City

Barcelona (1)

Le Kremlin Bicetre (1)

Paris (1)

Wermsdorf (1)

Worcester (1)

Condition

AMN (2)

AMN Gene Mutation (1)

Adrenoleukodystrophy (1)

Adrenomyeloneuropathy (1)

X-ALD (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2/phase 3 (1)

Sponsor

MedDay Pharmaceuticals SA (1)

SwanBio Therapeutics, Inc. (1)

Collaborator

Intervention

imitation procedure (1)

md1003 100 mg capsule (1)

placebo (1)

sbt101 (1)

Study Documents

Intervention Type

drug (1)

genetic (1)

procedure (1)

Funder Type

Industry (2)

Study Type

Interventional (2)

amn

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

AMN, AMN Gene Mutation, X-ALD Trial in Worcester (SBT101, Imitation Procedure)

Recruiting

AMN
+2 more

SBT101
Imitation Procedure

Worcester, Massachusetts

University of Massachusetts Chan Medical School

Jun 1, 2022

Adrenomyeloneuropathy, Adrenoleukodystrophy, AMN Trial in France, Germany, Spain (MD1003 100 mg capsule, Placebo)

Completed

Adrenomyeloneuropathy
+2 more

MD1003 100 mg capsule
Placebo

Le Kremlin Bicêtre, France
+3 more

Oct 6, 2017